logo

For the Inventor, By the Inventor

Hiroshima, Japan

Hiroshima University


USPTO Granted Patents = 258

% Expired Patents = 46.1



Forward Citations = 550

Loading Chart...
Loading Chart...

492 inventors (with patents filed for the assignee):

goldMedal Tetsushi Koide (17 out of 20 patents)

silverMedal Takashi Yamamoto (12 out of 42 patents)

bronzeMedal Tetsushi Sakuma (12 out of 13 patents)

4.  Akio Kuroda (12 out of 28 patents)

5.  Toru Yamamoto (10 out of 10 patents)

6.  Kazuo Takimiya (10 out of 19 patents)

7.  Hans Juergen Mattausch (10 out of 10 patents)

8.  Shin Yokoyama (8 out of 8 patents)

9.  Seiichiro Higashi (8 out of 8 patents)

10.  Haruo Matsuda (8 out of 9 patents)

11.  Masashi Kawamoto (7 out of 7 patents)

12.  Hiroki Nikawa (7 out of 8 patents)

13.  Hans Jurgen Mattausch (7 out of 8 patents)

14.  Kazuhisa Ono (7 out of 16 patents)

15.  Kazushige Koiwai (6 out of 19 patents)


Core Competencies:
Therapeutic Agent
Depression Treatment
Cell Penetrating Peptide
Microorganism
Blood Pressure Estimation
Exosome Isolation
Power Generation Device
Antisense Oligonucleotide
Construction Machine
Molecular Memory
Intestinal Flora Improvement
Photosensitizer

258 patents:

1. 12725936 - Array antenna device (2026-09-01),
2. 12709872 - CONSTRUCTION MACHINE (2026-08-18),
3. 12709863 - CONSTRUCTION MACHINE (2026-08-18),
4. 12703959 - Autonomous driving device for work machine (2026-08-11),
5. 12668954 - Bucket information acquisition device and construction machine provided with same (2026-06-30),
6. 12625476 - Control device (2026-05-12),
7. 12583918 - Therapeutic agent for urological cancer which is characterized by being administered with IL-6 inhibitor and CCR2 inhibitor in combination (2026-03-24),
8. 12573042 - Differentiation device, differentiation method for depression symptoms, determination method for level of depression symptoms, stratification method for depression patients, determination method for effects of treatment of depression symptoms, and brain activity training device (2026-03-10),
9. 12559522 - CELL PENETRATING PEPTIDE (2026-02-24),
10. 12534886 - Control device for construction machine and construction machine equipped with same (2026-01-27),
11. 12533514 - Percutaneous extracellular impedance control device (2026-01-27),
12. 12529211 - Measuring device, and construction machine (2026-01-20),
13. 12427228 - Meniscus regeneration material (2025-09-30),
14. 12416737 - Neutron detection element (2025-09-16),
15. 12392112 - Work machine state monitoring system and work machine state monitoring method (2025-08-19),
Hiroshima University is a prominent institution located in Hiroshima, Japan, specializing in biomedical engineering and related fields. The university focuses on innovative research and development in therapeutic agents, particularly for depression treatment, and advances in cell-penetrating peptides. Additionally, it explores cutting-edge technologies in microorganism applications, blood pressure estimation, exosome isolation, and power generation devices, alongside the development of antisense oligonucleotides, contributing significantly to the biomedical landscape.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Hiroshima University
258 Patents

#5 in Hiroshima, 729-3431

#594 in Japan

#3,390 in the World

Hiroshima, JP
Hiroshima, Japan

Hiroshima University

Forward Citations = 550

492 inventors:

goldMedal Tetsushi Koide (17 out of 20 patents)

silverMedal Takashi Yamamoto (12 out of 42 patents)

bronzeMedal Tetsushi Sakuma (12 out of 13 patents)

4.  Akio Kuroda (12 out of 28 patents)

5.  Toru Yamamoto (10 out of 10 patents)

Please report any incorrect information to [email protected]
Loading…